Effects of nisoldipine upon endothelial dysfunction following ischaemic and peroxidative injury in the perfused rat heart

Cardiovascular Research

Volumn 27, Issue 6, 1993, Pages 990-996

  Yaghi, Mohammad M ^a   Watts, John A ^a  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

Author keywords

Calcium antagonist; EDRF; Endothelium derived relaxing factor; Free radicals; Ischaemia; Nisoldipine; Oxidative stress; Peroxide; Reperfusion; Vascular injury

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; DILTIAZEM; GLYCERYL TRINITRATE; NISOLDIPINE; TERT BUTYL HYDROPEROXIDE; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENDOTHELIUM; HEART FUNCTION; HEART MUSCLE ISCHEMIA; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION;

ACETYLCHOLINE; ANIMAL; CORONARY VESSELS; ENDOTHELIUM, VASCULAR; HEART DISEASES; IN VITRO; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; NISOLDIPINE; NITROGLYCERIN; OXIDANTS; OXIDATION-REDUCTION; PEROXIDES; RATS; RATS, SPRAGUE-DAWLEY; SUPPORT, NON-U.S. GOV'T; TERT-BUTYLHYDROPEROXIDE; VASODILATION;

EID: 85047679946     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1093/cvr/27.6.990     Document Type: Article

References (36)

1. Gavin JB, Humphrey SM, Herdson PB. The no-reflow phenomenon in ischemic myocardium. Int Rev Exp Pathol 1983;25:361–83.
2. Rubanyi GM. Endothelium-derived relaxing and contracting factors. J Cell Biochem 1991;46:27–36.
3. VanBenthuysen KM, McMurtry IF, Horwitz LD. Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro. J Clin Invest 1987;79:265–74.
4. Watts JA, Chapat S, Johnson DE, Janis RA. Effects of nisoldipine upon vasoconstrictor responses and binding of endothelin-1 in ischemic and reperfused rat hearts. J Cardiovasc Pharmacol 1992;19:929–36.
5. Tsao PS, Lefer AM. Time course and mechanism of endothelial dysfunction in isolated ischemic- and hypoxic-perfused rat hearts. Am J Physiol 1990;259:H1660–6.
6. Quillen JE, Sellke FW, Brooks LA, Harrison DG. Ischemia-reperfusion impairs endothelium-dependent relaxation of coronary microvessels but does not affect large arteries. Circulation 1990;82:586–94.
7. Headrick JP, Angello DA, Berne RM. Effects of brief coronary occlusion and reperfusion on porcine coronary artery reactivity. Circulation 1990;82:2163–9.
8. Tsao PS, Aoki N, Lefer DJ, Johnson G, Lefer AM. Time course of endothelial dysfunction and myocardial injury during myocardial ischemia and reperfusion in the cat. Circulation 1990;82:1402–12.
9. Ma XL, Tsao PS, Viehman GE, Lefer AM. Neutrophil-mediated vasoconstriction and endothelial dysfunction in low-flow perfusion-reperfused cat coronary artery. Circ Res 1991;69:95–106.
10. 2+ antagonists. J Mol Cell Cardiol 1986;18(suppl 4):71–75.
11. Nayler WG. Calcium antagonists. New York: Academic Press, 1988:157–76.
12. Kazda S, Garthoff B, Meyer H, et al. Pharmacology of a new calcium antagonistic compound, isobutyl methyl 1, 4-dihydro-2, 6-dimethyl-4-(2-nitrophenyl)-3, 5-pyridinedicarboxylate (nisoldipine, Bay k 5552). Arzneimittelforschung 1980;30:2144–62.
13. Watts JA, Whipple JP, Hatley AA. A low concentration of nisoldipine reduces ischemic heart injury: enhanced reflow and recovery of contractile function without energy preservation during ischemia. J Mol Cell Cardiol 1987;19:809–17.
14. Watts JA, Hawes EM. Jenkins SH, Williams TC. Effects of nisoldipine on the no-reflow phenomenon in globally ischemic rat hearts. J Cardiovasc Pharmacol 1990;16:487–94.
15. Tilton RG. Watts JA, Land MP. Larson KB, Sutera SP, Williamson JR. Discordant effects of nisoldipine on coronary vascular resistance and permeability changes during reflow after ischemia in isolated rabbit hearts. J Mol Cell Cardiol 1991;23:861–72.
16. Nayler WG, Britnell S. Calcium antagonists and tissue protection. J Cardiovasc Pharmacol 1991;18(suppl 1):S1–5.
17. Marczin N. Ryan US. Catravas JD. Effects of oxidant stress on endothelium-derived relaxing factor-induced and nitrovasodilator-induced cGMP accumulation in vascular cells in culture. Circ Res 1992;70:326–40.
18. Lefer AM, Aoki N, Mulloy D. Coronary endothelium-protective effects of difibrotide in ischaemia and reperfusion. Naunvn Schmiedebergs Arch Pharmacol 1990;341:246–50.
19. Hladovec J. The influence of calcium antagonists on endothelium. Arzneimittelforschung 1979;29:1101–3.
20. Karasawa A, Rochester JA, Ma XL, Lefer AM. Protection of endothelium damage and systemic shock by benipidine, a calcium antagonist, in rats subjected to splanchnic ischemia and reperfusion. Circ Shock 1991;33:135–41.
21. Mügge A, Peterson T, Harrison DG. Release of nitrogen oxides from cultured bovine aortic endothelial cells is not impaired by calcium channel antagonists. Circulation 1991;83:1404–9.
22. Bossu JL, Elhamdani A, Feltz A, Tanzi F, Aunis D, Thierse D. Voltage-gated Ca entry in isolated bovine capillary endothelial cells: evidence of a new type of BAY K 8644-sensitive channel. Pflügers Arch 1992;420:200–7.
23. Mak T, Boehme P, Weglicki WB. Antioxidant effects of calcium channel blockers against free radical injury in endothelial cells. Correlation of protection with preservation of glutathione levels. Circ Res 1992;70:1099–103.
24. Timerman AP, Altschuld RA, Hohl CM, Brierley GP, Merola AJ. Cellular glutathione and the response of adult rat heart myocytes to oxidant stress. J Mol Cell Cardiol 1990;22:565–75.
25. Zwizinski CW, Schmid HHO. Peroxidative damage to cardiac mitochondria: identification and purification of modified adenine nucleotide translocase. Arch Biochem Bioplivs 1992;294:178–83.
26. Herbette LG. VantErve YMH. Rhodes DG. Interaction of 1.4 dihydropyridine calcium channel antagonists with biological membranes: lipid bilayer partitioning could occur before drug binding to receptors. J Mol Cell Cardiol 1989;21:187–201.
27. Janis RA, Shrinkhande AV, Greguski R. Pan M, Scriabine A. Review of nisoldipine binding sites. In: Hugenholtz PG, Meyer J, eds. Nisoldipine 1987. New York: Springer-Verlag, 1987:27–35.
28. Li YL, Fu SX, Li YS. Prophylactic effects of m-nisoldipine and nisoldipine on reperfusion arrhythmias exacerbated by free radical generating system in Langendorff heart of rat. Acta Pharmacol Sin 1989;10:310–5.
29. Herbaczynska-Cedro K, Gordon-Majszak W. Nisoldipine inhibits lipid peroxidation induced by coronary occlusion in pig myocardium. Cardiovasc Res 1990;24:683–7.
30. Kelm M, Schrader J. Nitric oxide release from the isolated guinea pig heart. Eur J Pharmacol 1988;155:317–21.
31. Rees DD, Palmer RMJ, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol 1989;96:418–24.
32. Noack E, Murphy M. Vasodilation and oxygen radical scavenging by nitric oxide/EDRF and organic nitrovasodilators. In: Sies H, ed. Oxidative stress: oxidants and antioxidants. New York: Academic Press, 1991:445–87.
33. Siegfried MR, Erhardt J, Rider T, Ma XL, Lefer AM. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion. J Pharmacol Exp Ther 1992;260:668–75.
34. Watanabe T, Suzuki N, Shimamoto N, Fujino M, Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res 1991;69:370–7.
35. Topouzis S, Huggins JP, Pelton JT, Miller RC. Modulation by endothelium of the responses induced by endothelin-1 and by some of its analogues in rat isolated aorta. Br J Pharmacol 1991;102:545–9.
36. Takayanagi R, Kitazumi K, Takasaki C, et al. Presence of nonselective type of endothelin receptor on vascular endothelium and its linkage to vasodilation. FEBS Lett 1991;282:103–6.